References
- 1. Baughman RP, Culver DA, Judson MA, Carolina S. Concise Clinical Review A Concise Review of Pulmonary Sarcoidosis. 2(11). doi:10.1164/rccm.201006-0865CI10.1164/rccm.201006-0865CI308127821037016
- 2. Thomas KW, Hunninghake GW. Sarcoidosis. 2015;289(24).10.1001/jama.289.24.330012824213
- 3. Ms PU, Ryu JH, Mph ELM. Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis. Mayo Clin Proc Innov Qual Outcomes. 2019;3(3):358-375. doi:10.1016/j.mayocpiqo.2019.04.00610.1016/j.mayocpiqo.2019.04.006671383931485575
- 4. Baughman RP, Field S, Costabel U, et al. Sarcoidosis in America Analysis Based on Health Care Use. 2016;13(8). doi:10.1513/AnnalsATS.201511-760OC10.1513/AnnalsATS.201511-760OC27509154
- 5. Treatment P. SARCOIDOSIS TREATMENT GUIDELINES.
- 6. Nunes H, Bouvry D, Soler P, Valeyre D. Orphanet Journal of Rare. 2007;8:1-8. doi:10.1186/1750-1172-2-4610.1186/1750-1172-2-46216920718021432
- 7. The TOF, Adopted WAS, The BY, Of O, The BY. Statement on Sarcoidosis. 1999;(3).
- 8. Ierce TADABUP, Argolis MAM, Azzuk MAAR. Sarcoidosis: still a mystery? 2001;75205:8-12.
- 9. Higgs R. Prognosis in sarcoidosis. 1984;288(May):1557-1558.10.1136/bmj.288.6430.155714412296426643
- 10. Ungprasert P, Clinic C, Crowson CS, Matteson E. Outcome of pulmonary sarcoidosis?: A population-based study 1976-2013 Outcome of pulmonary sarcoidosis?: a population-based study. 2018;(August 2019).10.1038/ajg.2017.231562911028872150
- 11. Costabel U, Hunninghake GW, Statement S. EDITORIAL ATS / ERS / WASOG statement on sarcoidosis. 1999:735-737.10.1034/j.1399-3003.1999.14d02.x10573213